期刊文献+

噻托嗅铵粉雾剂治疗慢阻肺疗效观察 被引量:2

Curative Effect Observation of Tiotropium Bromide Powder for Inhalation in the Treatment of Chronic Obstructive Pulmonary Disease
在线阅读 下载PDF
导出
摘要 目的 对慢阻肺患者应用噻托嗅铵粉雾剂治疗的临床疗效进行观察研究。方法 选取于2014年2月-2016年1月在我院接受治疗的慢阻肺患者103例,并随机分为参照组(49例)和实验组(54例),对分别应用异丙托溴铵气雾吸入剂和噻托嗅铵粉雾剂的治疗效果进行对照研究。结果 实验组患者的显效率明显高于参照组(61.11%vs.38.78%),治疗总有效率明显高于参照组(90.74%vs.73.47%),组间差异有统计学意义(P〈0.05)。结论 慢阻肺患者应用噻托嗅铵粉雾剂治疗具有较好的临床疗效。 Objective To discuss the clinical effect of Tiotropium Bromide Powder For Inhalation in treatment of obstructive pulmonary disease. Methods From February 2014 to January 2016, 103 patients with chronic obstructive pulmonary disease who were treated in our hospital were divided into control group (49 patients) and experience group (54 patients) randomly; and then make a comparative analysis between Ipratropium Bromide aerosol inhalation treatment effect with Tiotropium Bromide inhalation powder treatment effect between two groups. Results Patients’explicit efficacy in experience group was higher than that in control group (61.11% vs. 38.78%), and treatment efficiency inexperience group was also higher than that in control group (90.74% vs. 73.47%); there was a differential between two groups, which showed significant difference (P〈0.05). Conclusion Tiotropium Bromide inhalation powder is quite effective in treatment of obstructive pulmonary disease.
作者 陈音 陈复辉
出处 《中国继续医学教育》 2016年第18期154-155,共2页 China Continuing Medical Education
关键词 噻托嗅铵粉雾剂 治疗 慢阻肺 临床疗效 Tiotropium bromide inhalation powder Treatment Obstructive pulmonary disease Clinical efficacy
  • 相关文献

参考文献8

二级参考文献71

  • 1胡云芬.噻托嗅铵粉雾剂治疗慢阻肺的疗效分析[J].求医问药(下半月刊),2012,10(12):739-740. 被引量:8
  • 2陈丽军.噻托溴铵粉雾剂治疗慢性阻塞性肺气肿的疗效分析[J].求医问药(下半月),2013(4):299-299. 被引量:5
  • 3陈飞飞,刘俊刚,单俊好.噻托溴铵对老年慢性阻塞性肺病患者肺功能及生活质量的影响[J].中国老年学杂志,2015,35(1):26-27. 被引量:31
  • 4GOLD EXECUTIVE COMMITTEE.Global strategy for the diagnosis management and prevention of chronic obstructive pulmonary disease(Revised 2011).www.goldcopd.com.
  • 5RALLA G S,YORK T P,EDMISTON J S,et al.Proteomic biomarkers in plasma that differentiate rapid and slow decline in lung function in adult cigarette smokers with chronic obstructive pulmonary disease (copd)[J].Anal Bioanal Chem,2010,397(5):1 809-1 819.
  • 6中华医学会呼吸病学会慢性阻塞性肺疾病组.慢性阻塞性肺病组诊治指南(2013年修订版)[J].中华结核和呼吸杂志,2013,36(4):1-10.
  • 7CELLIBR,COTECG,MATINJM,etal.Theboay-mass index,ailrflow obstruction,dyspnea,and exercise capacity index in chronic obstruetive pulmonary disease[J].N Engl J Med,2004,350(10):1 005-1 012.
  • 8ATS Committee on Profieieney Standards for Clinical Pulmonary Function Laboratories.ATS statemenl:guidelines for the six-minute walk test.Am J Respir Crit Care Med,2002,166(1):111-117.
  • 9KOUMIS T,SAMUEL S.Tiotropium bromide:a new longacting bronehodilator for the treatment of chronic obstructive pulmonary disease[J].Clin Ther,2005,27 (4):377-392.
  • 10Ram FS.Tiotropium mist inhaler for COPD increases risk of mortality compared with placebo[J].Evid Based Med,2011,16(6):189-190.

共引文献111

同被引文献17

引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部